U.S. Markets open in 6 hrs 7 mins
  • S&P Futures

    4,399.25
    +5.50 (+0.13%)
     
  • Dow Futures

    34,927.00
    +93.00 (+0.27%)
     
  • Nasdaq Futures

    15,008.00
    -3.50 (-0.02%)
     
  • Russell 2000 Futures

    2,234.10
    +13.40 (+0.60%)
     
  • Crude Oil

    73.01
    +0.62 (+0.86%)
     
  • Gold

    1,818.50
    +18.80 (+1.04%)
     
  • Silver

    25.45
    +0.57 (+2.30%)
     
  • EUR/USD

    1.1872
    +0.0025 (+0.2137%)
     
  • 10-Yr Bond

    1.2610
    0.0000 (0.00%)
     
  • Vix

    18.31
    -1.05 (-5.42%)
     
  • GBP/USD

    1.3949
    +0.0041 (+0.2915%)
     
  • USD/JPY

    109.8420
    -0.0680 (-0.0619%)
     
  • BTC-USD

    40,003.69
    +343.99 (+0.87%)
     
  • CMC Crypto 200

    936.61
    +6.68 (+0.72%)
     
  • FTSE 100

    7,053.40
    +36.77 (+0.52%)
     
  • Nikkei 225

    27,782.42
    +200.76 (+0.73%)
     

Did You Participate In Any Of Bioventix's (LON:BVXP) Incredible 376% Return?

·3 min read

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, you can make far more than 100% on a really good stock. One great example is Bioventix PLC (LON:BVXP) which saw its share price drive 290% higher over five years. It's down 1.6% in the last seven days.

Check out our latest analysis for Bioventix

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

Over half a decade, Bioventix managed to grow its earnings per share at 18% a year. This EPS growth is lower than the 31% average annual increase in the share price. So it's fair to assume the market has a higher opinion of the business than it did five years ago. That's not necessarily surprising considering the five-year track record of earnings growth.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

earnings-per-share-growth
earnings-per-share-growth

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for Bioventix the TSR over the last 5 years was 376%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

While the broader market gained around 25% in the last year, Bioventix shareholders lost 2.3% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Longer term investors wouldn't be so upset, since they would have made 37%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. Importantly, we haven't analysed Bioventix's dividend history. This free visual report on its dividends is a must-read if you're thinking of buying.

We will like Bioventix better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on GB exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.